Update on Kaposi sarcoma-associated herpesvirus (KSHV or HHV8) - review.

Romanian Journal of Internal Medicine = Revue Roumaine De Médecine Interne
Nicoleta IftodeVictoria Aramă

Abstract

Human herpesvirus 8 (HHV8), also known as Kaposi sarcoma-associated herpesvirus (KSHV), is one of the few pathogens recognized as direct carcinogen, being involved in the pathogenesis of Kaposi sarcoma, primary effusion lymphoma and multicentric Castleman disease. KSHV is a relatively recently discovered virus, with still limited possibilities for diagnosis and treatment. Therefore, ongoing studies are trying to answer the main issues related to the management of KSHV infection and its associated diseases. This review updates the current knowledge of the KSHV infection, discussing aspects related to epidemiology, virological features, clinical manifestations, diagnosis and treatment.

References

Feb 1, 1988·The American Journal of Medicine·W QunibiS Taher
Apr 2, 1998·The New England Journal of Medicine·J N MartinD H Kedes
Jun 15, 2000·The American Journal of Pathology·M MercaderK E Foreman
Nov 9, 2000·The New England Journal of Medicine·M LuppiG Torelli
Mar 12, 2002·JAMA : the Journal of the American Medical Association·Massimo AndreoniGiovanni Rezza
Jan 15, 2003·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R TedeschiP De Paoli
Apr 2, 2003·The Journal of Antimicrobial Chemotherapy·Justin StebbingBrian Gazzard
Aug 16, 2003·Medical Microbiology and Immunology·P A ReichartC Bendick
Sep 1, 1962·The Journal of Pediatrics·D B JELLIFFEJ N DAVIES
Feb 6, 2004·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Anne-Geneviève MarcelinElisabeth Dussaix
Jun 16, 2007·The Journal of Infectious Diseases·Eric A EngelsJames J Goedert
Sep 28, 2007·The New England Journal of Medicine·Toby MaurerKieron Leslie
Apr 8, 2009·The Lancet Oncology·Véronique BouvardUNKNOWN WHO International Agency for Research on Cancer Monograph Working Group
Sep 25, 2010·Nature Reviews. Cancer·Enrique A MesriChris Boshoff
Mar 29, 2011·Advances in Dental Research·J N Martin
May 18, 2013·International Journal of Dermatology·Mahnaz Fatahzadeh, Robert A Schwartz
Aug 19, 2016·Journal of Blood Medicine·Kah-Lok ChanSimon J Harrison
Jan 30, 2018·Journal of the European Academy of Dermatology and Venereology : JEADV·D DenisN Dupin
Oct 1, 2018·Current Opinion in Virology·Oliver MannersAdrian Whitehouse
Nov 13, 2018·Mediterranean Journal of Hematology and Infectious Diseases·Maria Luisa Calabrò, Ronit Sarid
Nov 16, 2018·Proceedings of the National Academy of Sciences of the United States of America·Rachele BigiDirk P Dittmer
Feb 2, 2019·Nature Reviews. Disease Primers·Ethel CesarmanDenise Whitby
May 17, 2019·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Celeste LebbeUNKNOWN European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organisation for Rese
Aug 8, 2019·JAAD Case Reports·Jiasen WangMisha Koshelev
Feb 15, 2020·BMC Research Notes·Alessandra IncaniFabrizio Angius

❮ Previous
Next ❯

Citations

Sep 2, 2021·Scientific Reports·Gervillien Arnold MalongaAnne-Geneviève Marcelin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Castleman Disease

Castleman disease is a rare disorder that involves an overgrowth of cells in the lymph nodes. Unicentric Castleman disease affects one lymph node, usually in the chest or abdomen. Multicentric Castleman disease affects multiple lymph nodes, commonly located in the neck, collarbone, underarm and groin areas. Discover the latest research on Castleman disease here.